文献速递临床试验与 GCP医学人工智能与信息学真实世界研究与卫生经济

评估增强型电子健康记录 facilitated 癌症症状控制(E2C2)效果与实施的务实整群随机试验

Pragmatic cluster randomized trial to evaluate effectiveness and implementation of enhanced EHR-facilitated cancer symptom control (E2C2).
PubMed 文献 · Trials · 2020-06-05

该研究为混合2型阶梯楔形务实整群随机临床试验,在五家医院 clinician 团队中评估指南知情的EHR辅助癌症症状控制(E2C2)照护模式。干预分两级:一级为低接触自动化自我管理支持,二级为护士管理的协作照护。同时评估多层面循证实施策略对采纳和患者结局的影响,并混合方法分析老年和农村患者差异。

要点

  • E2C2为指南知情的EHR辅助症状控制模式,分两级干预。
  • 一级提供低接触自动化自我管理支持,二级为护士管理协作照护。
  • 试验评估实施策略对患者和临床结局的影响及差异。

核心结论

  • E2C2提供务实可扩展的指南基于症状和功能管理方法,可通过修改集中EHR算法高效传播和更新。

研究设计与样本

  • 混合2型阶梯楔形务实整群随机临床试验,五家医院 clinician 团队随机分步接受E2C2干预。

关键数值与推荐

  • 一级干预针对报告中度睡眠障碍、疼痛、焦虑、抑郁、精力不足或身体功能受限的患者提供低接触自动化自我管理支持。
  • 二级干预针对报告更严重症状或功能受限的患者提供护士管理协作照护。

临床怎么用

  • 临床可采用EHR嵌入算法驱动症状评估和分级管理,支持癌症患者症状控制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prevalence of inadequate symptom control among cancer patients is quite high despite the availability of definitive care guidelines and accurate and efficient assessment tools. METHODS: We will conduct a hybrid type 2 stepped wedge pragmatic cluster randomized clinical trial to evaluate a guideline-informed enhanced, electronic health record (EHR)-facilitated cancer symptom control (E2C2) care model. Teams of clinicians at five hospitals that care for patients with various cancers will be randomly assigned in steps to the E2C2 intervention. The E2C2 intervention will have two levels of care: level 1 will offer low-touch, automated self-management support for patients reporting moderate sleep disturbance, pain, anxiety, depression, and energy deficit symptoms or limitations in physical function (or both). Level 2 will offer nurse-managed collaborative care for patients reporting more intense (severe) symptoms or functional limitations (or both). By surveying and interviewing clinical staff, we will also evaluate whether the use of a multifaceted, evidence-based implementation strategy to support adoption and use of the E2C2 technologies improves patient and clinical outcomes. Finally, we will conduct a mixed methods evaluation to identify disparities in the adoption and implementation of the E2C2 intervention among elderly and rural-dwelling patients with cancer. DISCUSSION: The E2C2 intervention offers a pragmatic, scalable approach to delivering guideline-based symptom and function management for cancer patients. Since discrete EHR-imbedded algorithms drive defining aspects of the intervention, the approach can be efficiently disseminated and updated by specifying and modifying these centralized EHR algorithms. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03892967. Registered on 25 March 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Finney Rutten LJ, Ruddy KJ, Chlan LL, et al. Pragmatic cluster randomized trial to evaluate effectiveness and implementation of enhanced EHR-facilitated cancer symptom control (E2C2). Trials. 2020. PMID: 32503661. doi:10.1186/s13063-020-04335-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。